Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Retinoblastoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Etoposide 4Busulfan 4Thiotepa 3Melphalan 3Ifosfamide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Mesna 2sargramostim 1omburtamab I-131 1etoposide phosphate 1entinostat 1becatecarin 1alvocidib 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Tamoxifen 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Paclitaxel 1Leukapheresis 1LY2940680 1Immunologic Techniques 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × becatecarin × Other solid neoplasm × Clear all
NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
200 enrolled
CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡